Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.8%

3 terminated/withdrawn out of 397 trials

Success Rate

96.3%

+9.8% vs industry average

Late-Stage Pipeline

16%

62 trials in Phase 3/4

Results Transparency

1%

1 of 79 completed trials have results

Key Signals

110 recruiting1 with results

Enrollment Performance

Analytics

N/A
86(38.4%)
Phase 2
44(19.6%)
Phase 3
34(15.2%)
Phase 4
28(12.5%)
Phase 1
24(10.7%)
Early Phase 1
8(3.6%)
224Total
N/A(86)
Phase 2(44)
Phase 3(34)
Phase 4(28)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (397)

Showing 20 of 397 trials
NCT04699721Phase 2Active Not Recruiting

Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC

Role: lead

NCT05638776Phase 2Completed

Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Diffusion Capacity Defect by REGEND001 Cell Therapy

Role: collaborator

NCT06238232Not ApplicableCompleted

68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism: The GAPA Randomized Clinical Trial

Role: collaborator

NCT07840950Not ApplicableNot Yet Recruiting

Effects of Rosa Roxburghii Tratt Freeze-Dried Powder on Carotid Atherosclerotic Plaques: A Real-World Study

Role: lead

NCT07833410Recruiting

Chinese Multicenter Cohort Study of Intracerebral Hemorrhage

Role: lead

NCT06503939Completed

Etiology Analysis of Chronic Cough After COVID-19 Infection and Research on the Efficacy of ICS or ICS/LABA

Role: lead

NCT07744659Not ApplicableRecruiting

Spinal Cord Stimulation for Poststroke Spasticity

Role: collaborator

NCT06514781Completed

The Application of Different Sedation Protocols in ICU Patients With Severe Pneumonia

Role: lead

NCT07115459Recruiting

Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring

Role: lead

NCT05004441Phase 2Completed

Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer

Role: collaborator

NCT07690306Enrolling By Invitation

Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT

Role: lead

NCT07817927Not ApplicableCompleted

Posterior Transforaminal Debridement and Fusion Without Costotransversectomy for Thoracic Pyogenic Vertebral Osteomyelitis

Role: lead

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: collaborator

NCT06763289Active Not Recruiting

Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: cfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection

Role: collaborator

NCT07361796Not ApplicableRecruiting

The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster

Role: collaborator

NCT07083154Phase 3Recruiting

Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)

Role: collaborator

NCT05198154Active Not Recruiting

ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

Role: collaborator

NCT06218485Not ApplicableActive Not Recruiting

FFR Versus IVUS With Angiography-Derived FFR for Clinical Outcomes in Patients With Coronary Artery Disease

Role: collaborator

NCT06495840Withdrawn

Postoperative Anxiety and Depression Among Older Chinese Patients

Role: collaborator

NCT06990412Not ApplicableCompleted

A Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Wireless Brain-Computer Interface（BCI）System NEO in Patients With Tetraplegia

Role: collaborator